[Federal Register Volume 71, Number 246 (Friday, December 22, 2006)]
[Notices]
[Page 77065]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-21884]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 15, 2006, Johnson 
Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West 
Deptford, New Jersey 08066, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Remifentanil (9739), a basic class of controlled 
substance listed in schedule II.
    The company plans on producing this item for sale to its customers, 
who are final dosage manufacturers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than February 20, 2007.

    Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-21884 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P